ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2015
Surgical treatment options for aggressive osteoblastoma in the mobile spine.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Balancing safe resection and spinal stability in osteoblastoma and osteoid osteoma: a retrospective study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026Observational
- Article
- Chronic neck pain in a child: a case of osteoblastoma of the C5 cervical vertebra.BMJ case reports · 2024Article
- Osteoblastoma of the patella, a rare benign bone tumor with an uncommon site: A case report.Molecular and clinical oncology · 2023Article
- Surgical treatment of spinal tenosynovial giant cell tumor: Experience from a single center and literature review.Frontiers in oncology · 2022Article
- Intralesional Marginal Resection for Osteoblastoma in the Mobile Spine: Experience From a Single Center.Frontiers in surgery · 2022Article
- A Retrospective Evaluation of Operative and Postoperative Outcomes in Patients with Spinal Metastases from a Single Center to Compare Vertebrectomy with Combined Vertebrectomy and Radiofrequency Ablation.Medical science monitor : international medical journal of experimental and clinical research · 2021Article
- Osteoblastoma: When the Treatment Is Not Minimally Invasive, an Overview.Journal of clinical medicine · 2021Article
- The one-in-all diagnostic value ofJournal of orthopaedic surgery and research · 2020Article
- Differentiation of spinal metastases originated from lung and other cancers using radiomics and deep learning based on DCE-MRI.Magnetic resonance imaging · 2019Article
- Diagnostic and Management Options of Osteoblastoma in the Spine.Medical science monitor : international medical journal of experimental and clinical research · 2019Review
- A rare case of osteoblastoma combined with severe scoliosis deformity, coronal and sagittal imbalance.BMC musculoskeletal disorders · 2017Article
- Percutaneous radiofrequency ablation for spinal osteoid osteoma and osteoblastoma.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2017Article
- Aggressive osteoblastoma of the cervical spine involving the canal and vertebral artery: a case report.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2017Article
- Surgical management of an osteoblastoma involving the entire C2 vertebra and a review of literature.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOsteoblastoma (OBL) is a benign bone tumor with considerable recurrence potential. Resection is the mainstay for the treatment of Enneking stage 3 (st. 3) OBL. This retrospective study aimed to verify the appropriate surgical strategy for st. 3 lesions in the mobile spine.
methods19 cases of st. 3 OBL was diagnosed between 2001 and 2011. Clinical, radiological, surgical, and follow-up data were analyzed. This series included 14 men and 5 women and the mean age at diagnosis was 30.4 years. The lesions were located in the cervical spine in ten cases, in the thoracic spine in eight, and in the lumbar spine in one. Fourteen patients were surgically treated for the first time (intact cases), and five were referred to us after previous unsuccessful treatments (non-intact cases).
resultsBefore 2008, 11 patients underwent curettage followed by radiotherapy, including 5 non-intact cases and 6 intact cases. Tumor recurrence was observed in all five non-intact cases and four of the six intact cases. After 2008, eight intact patients underwent intralesional vertebrectomy, including six who underwent piecemeal total vertebrectomy and two who underwent intralesional en bloc vertebrectomy. All the eight patients had embolization before surgery. 18 patients had an average 67.3 months (range 36-148 months) of follow-up. Recurrence was not observed in any of these eight cases with intralesional vertebrectomy.
conclusionIntralesional total vertebrectomy might be an appropriate choice for intact st. 3 OBL spine lesions. More cases with longer follow-up periods should be recruited in the future to better understand the treatment options available for this disease.
Indexed as
Identifiers
25847727What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.